Artal International Management S.A., Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 82,368 shares at $13.06 ($1.1M) on 2018-06-18, disclosed to the SEC on 2018-06-18.
Open-market purchase of $1.1M LXRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.66 | 9,200 | $116K | 10.9% |
| 2 | $13.06 | 36,584 | $478K | 44.6% |
| 3 | $13.06 | 36,584 | $478K | 44.6% |
| Total | $13.02 avg | 82,368 | $1.1M | 100% |
| Filing → |
| LXRX | BUY | 2018-06-07 | $8.2M | — | Filing → |
| LXRX | BUY | 2018-05-30 | $7.3M | — | Filing → |
| WTW | BUY | 2014-08-14 | $2.9M | — | Filing → |